All of the aforementioned results suggested at the first time that KMT2A activated the translocation of β-catenin into the nucleus of gastric cancer cells and then served as a coactivator of KLF11, which promoted the expression of specific gastric cancer stemness-related molecules, including SOX2 and FOXM1. Here, KLF11 is linked to gastric cancer.